Indications and uses
temporarily protects and helps relieve minor skin irritation and itching due to: • eczema • rashes
temporarily protects and helps relieve minor skin irritation and itching due to: • eczema • rashes
apply as needed, or as directed by your doctor.
• store at room temperature • keep from freezing
Colloidal Oatmeal 1%
Skin Protectant
temporarily protects and helps relieve minor skin irritation and itching due to: • eczema • rashes
For external use only.
When using this product do not get into eyes.
Stop use and ask a doctor if
• condition worsens • symptoms last more than 7 days or clear up and occur again within a few days.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
apply as needed, or as directed by your doctor.
• store at room temperature • keep from freezing
cyclomethicone,microcrystalline wax, petrolatum(special fraction)
call 1-888-437-2753
Does not contain antibiotics.
Not tested on animals.
Distributed by:
The Theraplex Company, LLC
Memphis,TN 38119
Steroid Free
Fragrance Free
Paraben Free
Preservative Free
Gluten Free
Noncomedogenic
Hypoallergenic
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 240464 | colloidal oatmeal 1 % Topical Lotion | PSN | 5 |
| 1492753 | theraplex Eczema Therapy 1 % Topical Lotion | PSN | 5 |
| 1492753 | colloidal oatmeal 10 MG/ML Topical Lotion [Theraplex Eczema Therapy] | SBD | 5 |
| 240464 | colloidal oatmeal 10 MG/ML Topical Lotion | SCD | 5 |
| 240464 | colloidal oatmeal 1 % Topical Lotion | SY | 5 |
| 1492753 | Theraplex Eczema Therapy 1 % Topical Lotion | SY | 5 |
| 1492753 | Theraplex Eczema Therapy 10 MG/ML Topical Lotion | SY | 5 |
| Class | Version | Type | Effective |
|---|---|---|---|
| OATMEAL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20181113 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62917-350-01 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-20ca-fd44-e053-dadaa90aa01b | Theraplex |
| 62917-350-06 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-20ca-fd44-e053-dadaa90aa01b | Theraplex |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62917-350-01 | Theraplex Eczema Therapy Moisturizing skin protectant | 128 g in 1 TUBE | LOTION | 128 | 5 | |
| 62917-350-06 | Theraplex Eczema Therapy Moisturizing skin protectant | 170.1 g in 1 JAR | LOTION | 170.1 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OATMEAL | ACTIVE INGREDIENT | 8PI54V663Y | 3 | |
| OATMEAL | ACTIVE MOIETY | 8PI54V663Y | 3 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 3 | |
| MICROCRYSTALLINE WAX | INACTIVE INGREDIENT | XOF597Q3KY | 3 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62917-350 | 62917-350-01, 62917-350-06 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OATMEAL | 8PI54V663Y | ACTIB |
| CYCLOMETHICONE | NMQ347994Z | IACT |
| MICROCRYSTALLINE WAX | XOF597Q3KY | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MICROCRYSTALLINE WAX | MICROCRYSTALLINE WAX | XOF597Q3KY | CREAM / VAGINAL | 23 mg | ||
| MICROCRYSTALLINE WAX | MICROCRYSTALLINE WAX | XOF597Q3KY | CAPSULE, EXTENDED RELEASE / ORAL | 6 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | SOLUTION / TOPICAL | 11.57 %w/v | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| MICROCRYSTALLINE WAX | MICROCRYSTALLINE WAX | XOF597Q3KY | OINTMENT / TOPICAL | 3575 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| MICROCRYSTALLINE WAX | MICROCRYSTALLINE WAX | XOF597Q3KY | GEL / TOPICAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM, AUGMENTED / TOPICAL | 7.6 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | AEROSOL, FOAM / TOPICAL | 5.26 %w/w | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9d6e2374-7834-46e5-a368-2f5918706ebf | 47b50665-1909-411f-b6e0-d24602811c99 | 2018-02-22 | Warnings | 9d6e2374-7834-46e5-a368-2f5918706ebf 47b50665-1909-411f-b6e0-d24602811c99 |
Adverse event summaries are temporarily unavailable. Other product information remains available.